Phase II trial of ixabepilone in patients with cisplatin-refractory germ cell tumors.
Feldman DR; Kondagunta GV; Ginsberg MS; Ishill N; Patil S; Cestaro J; Obbens E; Sheinfeld J; Bosl GJ; Motzer RJ; Investigational New Drugs, 2007, vol. 25, issue 5, p 487, ISSN 01676997. ISBN 01676997.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef